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Abstract
Background: Perforation is a rare complication of gastric carcinoma, accounting for less than 1%
of all gastric cancer cases. The aim of the present study is to evaluate the prognostic value of
perforation and to point out the surgical treatment options.
Methods: A total of 10 patients with perforated gastric carcinoma were retrospectively reviewed
among 2564 consecutive cases of gastric cancer operated in three Centers belonging to the Italian
Research Group for Gastric Cancer. The clinicopathological features including tumor stage and
survival were analyzed and compared to literature data.
Results: Incidence rate was 0.39%. All patients underwent emergency surgery, being performed
gastrectomy in 6 patients (mortality 17%) and repair surgery in 4 patients (mortality 75%). The
survival of patients was related to the stage of the disease, with 2 long-survival cases.
Conclusion: Perforation usually occurs in advanced stages of gastric cancer; nevertheless
surgeons should not be always discouraged from a radical treatment of perforated gastric cancer,
since perforation even occurs in early stages and seems not to be a negative prognostic factor itself.
When possible, emergency gastrectomy should be performed, leaving repair surgery for
unresectable tumors. A two-stage treatment is a good treatment option for frail patients with
resectable tumors.
Background
Perforation of gastric carcinoma results in an acute
abdominal syndrome due to the spilled gastric contents
and the consequent peritonitis. It is a rare condition rep-
resenting less than 1% of gastric cancer cases in the reports
of the last years[1,2] and up to 6% in reports dated before
1980 [3-5]; it has been reported that about 10–16% of all
gastric perforations are caused by gastric carcinoma [6-9].
In most instances gastric carcinoma is not suspected as the
cause of perforation prior to emergency laparotomy and
the diagnosis of malignancy is often made only on post-
operative pathologic examination. It is often difficult to
recognize the kind of lesion that caused gastric perfora-
tion at the time of emergency surgery, particularly when
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The treatment should aim to manage both the emergency
condition of peritonitis and the oncologic technical
aspects of surgery: it may be hazardous to embark on a
major procedure observing the principles of radical onco-
logical surgery; on the other hand a limited procedure
only may jeopardize long-term survival in a patient with
potentially curable gastric malignancy. In order to further
understand the optimal management of patients with per-
forated gastric cancer, we reviewed the clinicopathological
features and surgical results in our experience, comparing
data with the International literature.
Methods
We reviewed the medical records of 2564 patients with
gastric cancer who had undergone surgical treatment in
three Centers belonging to the Italian Research Group for
Gastric Cancer (IRGGC): Dipartimento di Chirurgia Gen-
erale ed Oncologica, University of Siena, Istituto di Semei-
otica Chirurgica, University of Verona and Divisione di
Chirurgia 1, G.B. Morgagni Hospital, Forlì. Ten patients
(0.39%) were treated for perforated gastric carcinoma.
The clinicopathological features of all patients were ana-
lyzed on the basis of their medical records. Age and sex,
preoperative diagnosis, location of perforation, depth of
gastric wall invasion, absence or presence of lymph node
metastasis, type of surgery, degree of lymph node dissec-
tion, UICC stage and outcome of the patients were exam-
ined. Overall survival from the time of primary operation
was calculated using Kaplan-Meier estimates. A search of
the literature was conducted in the Medline database; the
terms "perforated", "perforation", "gastric cancer", "gas-
tric ulcer" were associated for the search and English lan-
guage journals only were selected.
Results
Clinicopathological features of patients are given in Table
1. The incidence rate of perforation among gastric carci-
noma was 0.39%. Most cases were tumors invading serosa
(4/6) and with metastatic lymph nodes (4/6). The disease
was more frequently in stages III/IV (7/10), but one case
(1/10) of stage I gastric cancer was also observed. All
patients underwent emergency surgery. In only 3 patients
on 10 a preoperative diagnosis of gastric carcinoma was
made. Table 2 shows surgical and postsurgical survival
data. Operations performed were gastrectomy in 6
patients and simple closure in 4 patients. Surgery-related
deaths were observed in 4 patients: 3 of them underwent
simple closure and 1 subtotal gastrectomy. All tumors
treated with simple closure were at clinical stage IV of the
disease and emergency gastrectomy was not performed
because of the advanced stage with adjacent organs inva-
sion. Five subtotal gastrectomies (4 D1 and 1 D2) and one
D3 total gastrectomy were performed. Three surgical and
two non-surgical complications were observed. The only
patient who survived surgery after simple repair died at
5.2 months from operation for the primary disease. The
only patient who underwent gastrectomy whose death
was surgery-related was 80 and presented cardiologic
comorbidity. Two patients underwent adjuvant chemo-
therapy and they both are still alive after 47.7 and 41.6
months after surgery, one with no evidence of disease and
the other with bone recurrence.
Discussion
Perforation is a rare complication of gastric cancer. In our
series an incidence of less than 1% (0.39%) was observed
comparable to the most recent studies[1,2]. Preoperative
diagnosis of malignancy is unusual, accounting for about
30% of cases[1,2,10]; the other patients are usually
accepted for acute abdomen at the Emergency Units
where generic preoperative diagnosis of gastroduodenal
perforation is made. The only preoperative feature that
may guide the surgeon is the age of the patient: perforated
gastric carcinoma usually occurs in patients with a mean
Table 1: Clinicopathological features of patients with perforated 
gastric cancer.
Variable Number of Patients
Age
Range (yr)/Mean 50–82/68
Sex
Male 6/10
Female 4/10
Preoperative diagnosis
Perforation 10/10
Cancer 3/10
Location
Lower third 8/10
Middle third 1/10
Upper third 1/10
Serosal invasion*
Absent 4/6
Present 2/6
Lauren histological type*
Diffuse 1/5
Intestinal 4/5
Lymph node metastasis*
Absent 4/6
Present 2/6
Stage of disease
I 1/10
II 2/10
III 3/10
IV 4/10
Surgery
Gastrectomy 6/10
Local repair 4/10
Lymph node dissection
Extended (D2, D3) 2/6
Limited (D0, D1) 4/6
*data not available for all patients.Page 2 of 6
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mean age of 51 years of the patients with perforated peptic
ulcers [9-13]. Even during surgery the gastric ulcer is often
diffucult to be characterized as benign or malignant by the
surgeon. Therefore a biopsy and frozen section should be
performed in all gastric perforations when a pathologist is
available. Histologic determination is fundamental for
the surgeon to choose the type of operation and to per-
form it with oncological criteria, for example considering
adequate distance from the lesion and the resection mar-
gin. Malignant gastric perforation is more often a manifes-
tation of advanced cancer with serosal invasion (55–82%)
and lymph node metastasis (57–67%). Nevertheless, as
confirmed by different observations[14,15], gastric cancer
can perforate at an early stage. Indeed at the pathologic
examination of specimens, the process of gastric wall per-
foration is sustained by infectious and ischaemic factors
due to the tumoral neovascularization which result in the
shedding of the neoplastic tissue[3,16].
It is still debated whether positive peritoneal cytology has
an independent prognostic impact in gastric cancer. Sev-
eral studies have noted free gastric cancer cells in the per-
itoneum to be associated with poor prognosis[17,18].
However, viable free cancer cells have not been demon-
strated in the peritoneal cavity of patients with perforated
gastric cancer and the metastatic efficiency of gastric can-
cer cells possibly shed during perforation is uncertain in
the presence of the peritonitis; different studies, included
the present one, report of long-term survivors[19]. When
a curative operation can be performed, survival rates after
gastric cancer perforation[1,20] appear similar to survival
rates observed in elective patients[21,22]. Moreover, Gert-
sch et al. demonstrated how the only factor predicting
long term survival is the TNM stage, while age or the size,
the location, the depth of infiltration and the histologic
grading of the tumor or a delay in treatment after perfora-
tion showed no correlation with long-term survival[10].
Earlier, in 1997, Adachi et al. reviewed 155 cases of perfo-
rated gastric cancer collected from the Japanese literature
finding that infiltrative gross type of the tumor, presence
of serosal invasion, presence of lymph node metastasis,
stage III-IV and curability of the tumor were the only neg-
ative prognostic factors influencing the 5-years survival
rate, while age, sex, location, histologic type and type of
lymph node dissection were not found to be significantly
related to the long term survival[1]. In another study of
Gertsch et al., the Authors compared three groups of
patients with perforated, bleeding and non-complicated
gastric cancer, finding that perforation, as well as bleed-
ing, does not significantly affect long term survival after
gastrectomy[23].
Treatment of choice is still debated. Table 3 shows the
results of our research in the International English litera-
ture. From the first study of Aird[24] in 1935 until the
early 1980's we found how the most frequent type of
operation performed for perforated gastric cancer was the
simple closure or the omental patch, sometimes associ-
ated with gastroenteroanastomosis. In these papers is also
shown the high surgery-related mortality of this type of
surgery, nevertheless surgeons seemed to prefer simple
repair, probably because malignant gastric perforation,
with consequent peritoneal dissemination of tumor cells,
was generally thought to be always a manifestation of ter-
minal disease. Of course, the high mortality of simple clo-
sure is also due to the different kind of patients who
undergo this type of minimal surgery: this approach is
usually preferred for minimal therapy in frail patients or
in advanced unresectable tumors. Therefore over the years
the resection rate has been increasing and the overall mor-
tality rate has been decreasing. In 2002 Lehnert et al.[9]
proposed the two-stage radical gastrectomy as the treat-
ment of choice in the majority of patients with perforated
gastric cancer: this approach aims to avoid major surgical
procedures in emergency performing a first-step simple
Table 2: Postsurgical survival data for patients with perforated gastric carcinoma.
Case Sex Age TNM Stage Type of surgery Comorbidities Postoperative 
Complications
Survival (months) Cause of death or 
Comments
1 M 52 T4N1M0 III DG-D1 Pulmonary - 47,67 CHT – Alive with bone 
recurrence
2 F 82 T4N1M0 III DG-D1 - - 16,53 Primary cancer
3 M 76 - IV Repair - Pulmonary heart <1 Surgery-related
4 F 78 T3N0MX II DG-D1 Cardiac - <1 Surgery-related
5 F 73 - IV Repair - Pulmonary embolism <1 Surgery-related
6 M 81 T2N0MX I DG-D1 - Anastomotic Leakage 18,80 Primary cancer
7 M 57 - IV Repair - - <1 Surgery-related
8 F 65 - IV Repair - Bleeding 5,20 Primary cancer
9 M 66 T2N1MX II DG-D2 - - 41,60 CHT – Alive
10 M 50 T3N2MX III TG-D3 - Bleeding 25,60 Primary cancer
DG, distal gastrectomy; TG, total gastrectomy; D1, D2, D3, lymph node dissection; CHT, adjuvant chemotherapy.Page 3 of 6
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gastrectomy with oncological radicality intent. This kind
of approach has been approved by Ozmen et al.[25] who
found that preoperative shock is a negative prognostic fac-
tor influencing surgery-related mortality.
Conclusion
From the the personal experience of the IRGGC and from
the studies reported in the literature we tried to make the
point for the treatment of choice of perforated gastric car-
cinoma. Perforated gastric carcinoma is not to be consid-
ered as a unique disease, but the surgeon should consider
the single elements that compose every peculiar clinical
case. The treatment of the peritonitis would require a min-
imal surgery in order to avoid major procedures in an
emergency situation; on the other hand the treatment of
gastric cancer would require an oncological-oriented sur-
gery in order to satisfy oncological radicality criteria.
These two aims are not always compatible in a single
emergency surgical treatment. The most important factors
to be recalled in the management of a patient with histo-
logical diagnosis of perforated gastric carcinoma are: 1)
the presence of preoperative shock[26]; 2) the gravity of
peritonitis; 3) the curability of the neoplasm; 4) eventual
comorbidities of the patient. If we add together points 1,
2 and 4 considering them as the general condition of the
patient, we may identify four classes of patients with dif-
ferent options for surgical treatment (Figure 1). If a patient
has a curable tumor and acceptable general condition, for
example no signs of shock, localized peritonitis and no
comorbidities, the treatment of choice seems to be radical
total or subtotal gastrectomy with associated D2 or D3
lymphadenectomy or, for a less aggressive approach, two-
stage radical gastrectomy. When general condition is good
but the tumor is at an advanced stage with no possibility
of R0 resection, a palliative gastrectomy, if technically pos-
sible, is recommended considering the minor surgery-
related mortality[27]. Two-stage radical gastrectomy
seems to find its peculiar indication when general condi-
tion is poor but a curative resection is possible, even
though this approach was never chosen in our experience.
Simple repair or omental patch are reserved only for those
patients with advanced stage disease and whose general
condition is poor. If a pathologist is not available and his-
tologic examination is not possible during surgery, we
suggest to perform a gastric resection, since for perforated
Table 3: Published series of patients with perforated gastric cancer.
Mortality (%)
Reference N° patients Incidence (%) Preoperative 
diagnosis (%)
N° Repair 
surgery
N° Gastrectomy Repair Gastrectomy Survival data
Aird 1935[24]* 38 - 7.5 31 7 22 (71) 0 -
McNealy 1938[4]* 63 4.0 33.8 47 7 39 (82) 2 (29) -
Casberg 1940[31] 5 2.4 0 5 0 4(80) - -
Bisgard 1945[5]* 115 2.8–6.0 3.2 80 15 59(74) 2(13) -
Larmi 1962[13] 19 3.0 42.1 16 4 8(50) 0 Survival range in resected cases 
18–42 months
Wilson 1966[12] 14 1.2 30.8 5 5 0 0 Survival range of patients with R0 
resection, 15–41 months; with 
R1-R2 4–15 months
Cortese 1972[11] 13 0.6 40.0 11 2 3(27) 0 Survival range of patients with R0 
resection, 14–108 months; with 
R1-R2 2 months
Stechenberg 
1981[3]
9 3.9 0 7 2 2(29) 0 Mean survival, 5 months (range 
1–18)
Siegert 1982[32] 4 2.3 25 0 4 - 0 Range of survival, 1–18 months
Miura 1985[20] 9 0.6 33.3 1 8 - - Median survival, 108 months 
(range, 4–144)
Gertsch 1995[10] 34 - 29.4 4 30 2(50) 5(17) Median survival stage I 50 
months; III, 17 months; IV 4 
months
Adachi 1997[1]* 155 0.5–3.6 34.7 27 128 19(70) 9(7) 5-years survival stage I-II, 76%; 
III-IV, 19%
Lehnert 2000[9] 23 1.8 39.1 12† 11 1(8) 2(18) 5-years survival R0, 50%; 2-years 
survival R1-R2, 9%
Kasakura 2002[2] 16 0.7 31.2 2‡ 14 1(50) 1(7) Median survival stage I-II 75 
months; III-IV, 4.8 months
Ozmen 2002[25] 14 3.0 35.7 3§ 11‡ 1(33) 4(36) -
IRGGC 2005 10 0.4 30.0 4 6 3(75) 1(17) See text and Table 2
* Collected series; † 5 patients underwent secondary radical gastrectomy; ‡ 1 patient underwent secondary radical gastrectomy; § 2 patients 
underwent secondary radical gastrectomy.Page 4 of 6
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for the better morbility and the lower rate of recurrence
[28-30]; only intraoperative hemodynamic instability
should limit operative selection to a faster procedure. In
both cases when the postoperative histologic examination
would assess the malignancy of the ulcer a secondary rad-
ical gastrectomy is mandatory.
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Decisional flow-chart for perforated gastric cancerFigure 1
Decisional flow-chart for perforated gastric cancer. General condition includes 3 factors: haemodynamics, 
gravity of peritonitis and comorbidities.
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